Important Information

Announcement by the Management Board of the Frankfurt Stock Exchange according to Sec. 50a para. 3 of the German Stock Exchange Act 

On 30 April 2025 the Management Board of the Frankfurt Stock Exchange revoked the admission to the sub-segment of the regulated market with additional obligations (Prime Standard) of the shares of Medigene AG, Planegg/Martinsried ex officio according to Sec. 57 Abs. 2 BörsO FWB, Sec. 42 para. 2 of the German Stock Exchange Act. For further information regarding trading please see the publication on xetra.com.

The decision is final and conclusive.

Date: 12 June 2025

Please refer to the announcement of the issuer.